Citigroup
AHCO icon

Citigroup’s AdaptHealth AHCO Stock Holding History

Citigroup’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$616K Sell
59,128
-38,610
-40% -$431K ﹤0.01% 3787
2026
Q1 		$1.16M Buy
97,738
+50,971
+109% +$522K ﹤0.01% 3018
2025
Q4 		$466K Buy
46,767
+5,350
+13% +$51.1K ﹤0.01% 3610
2025
Q3 		$371K Sell
41,417
-49,392
-54% -$457K ﹤0.01% 3722
2025
Q2 		$856K Sell
90,809
-68,787
-43% -$607K ﹤0.01% 3278
2025
Q1 		$1.73M Buy
159,596
+14,317
+10% +$144K ﹤0.01% 2827
2024
Q4 		$1.38M Buy
145,279
+13,147
+10% +$133K ﹤0.01% 3107
2024
Q3 		$1.48M Buy
132,132
+64,053
+94% +$681K ﹤0.01% 2932
2024
Q2 		$681K Buy
68,079
+6,005
+10% +$61K ﹤0.01% 3188
2024
Q1 		$714K Buy
62,074
+7,632
+14% +$64.8K ﹤0.01% 3295
2023
Q4 		$397K Buy
54,442
+21,864
+67% +$172K ﹤0.01% 3566
2023
Q3 		$296K Sell
32,578
-21,309
-40% -$255K ﹤0.01% 3421
2023
Q2 		$656K Buy
53,887
+15,536
+41% +$173K ﹤0.01% 3176
2023
Q1 		$477K Sell
38,351
-7,450
-16% -$137K ﹤0.01% 3160
2022
Q4 		$880K Buy
45,801
+9,608
+27% +$203K ﹤0.01% 2727
2022
Q3 		$680K Buy
36,193
+29,204
+418% +$600K ﹤0.01% 3011
2022
Q2 		$126K Buy
6,989
+1,161
+20% +$18.9K ﹤0.01% 4093
2022
Q1 		$94K Sell
5,828
-14,055
-71% -$253K ﹤0.01% 4443
2021
Q4 		$486K Buy
19,883
+10,205
+105% +$240K ﹤0.01% 3817
2021
Q3 		$225K Buy
9,678
+4,866
+101% +$118K ﹤0.01% 4059
2021
Q2 		$132K Sell
4,812
-245
-5% -$6.99K ﹤0.01% 4415
2021
Q1 		$186K Sell
5,057
-4,559
-47% -$161K ﹤0.01% 4048
2020
Q4 		$361K Buy
9,616
+8,416
+701% +$260K ﹤0.01% 4497
2020
Q3 		$26K Buy
1,200
+161
+15% +$3.38K ﹤0.01% 5999
2020
Q2 		$17K Sell
1,039
-1,098
-51% -$18.4K ﹤0.01% 6728
2020
Q1 		$34K Buy
2,137
+1,204
+129% +$17K ﹤0.01% 6303
2019
Q4 		$10K Buy
+933
New +$9.27K ﹤0.01% 7195

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citigroup's AHCO Position: Q2 2026 in Review

Citigroup reduced its AdaptHealth (AHCO) stake by 40% in Q2 2026, selling an estimated $431K and leaving 59,128 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #3787.

Citigroup first reported a position in AHCO in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.73M in Q1 2025. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Citigroup held 59,128 shares of AdaptHealth worth $616K as of Q2 2026.
  • Citigroup sold 38,610 AdaptHealth shares in Q2 2026, an estimated $431K.
  • AdaptHealth made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3787 holding.
  • Citigroup first reported a position in AdaptHealth in Q4 2019 and has held it in 27 quarters since.
  • Citigroup's AdaptHealth position peaked at $1.73M in Q1 2025.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.